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Central  angiotensinergic  and  cholinergic  mechanisms  have important  role  in the  cardiovascular  regulation.
AV3V  lesions  reduce  the sympathetic  activation  produced  by  ANG  II injected  into  the  RVLM.
Signals  from  the AV3V  region  are  important  for  the maintenance  of  a normal  excitability  of  the  RVLM  neurons.
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Injection  of  l-glutamate  (GLU)  into  the  rostral  ventrolateral  medulla  (RVLM)  produces  sympathetically-
mediated  pressor  responses  that  depend  on the  integrity  of  the  tissue  surrounding  the  anteroventral  third
ventricle  (AV3V  region).  The  injection  of angiotensin  II (ANG  II) or  the cholinergic  agonist  carbachol  into
the  RVLM  also  produces  pressor  responses.  In the present  study, we  investigated  if the  lesion  of  the  AV3V
region  affects  the  pressor  responses  to  ANG  II or carbachol  injected  into  the RVLM  in unanesthetized  rats.
Male  Holtzman  rats  with  sham  or electrolytic  AV3V  lesions  and  a stainless  steel  cannula  implanted  intoympathetic
VLM
ngiotensinergic
ressor response
ypertension
the  RVLM  were  used.  The  pressor  responses  to ANG  II (200  ng/100  nl)  injected  into  the  RVLM  were  reduced
by  acute  (1  day)  (12  ±  3  vs.  sham  lesions:  26  ±  4  mmHg)  or chronic  (15 days)  AV3V  lesions  (12  ± 5  vs.
sham  lesions:  27  ±  4 mmHg),  whereas  acute  or  chronic  AV3V  lesions  did not  affect  the  pressor  responses
to  carbachol  (1  nmol/100  nl)  injected  into  the  RVLM.  The  present  results  suggest  that  the  AV3V  region
modulates  the excitability  of the  RVLM  neurons  involved  with  the pressor  response  produced  by  the
activation  of  angiotensinergic  mechanisms  in  this  area.. Introduction
Important mechanisms involved in the control of cardiovascular
unction like those that affect vasopressin secretion and sympa-
hetic activity are present in the forebrain and in the hindbrain
10,11,34]. The basic control of the cardiovascular function depends
n a medullary circuitry involving the nucleus of the solitary tract
NTS), the nucleus ambiguus (NA) and the ventrolateral medulla
caudal and rostral) that controls the autonomic discharges to
he cardiovascular system [23,37]. Although the activity of the
edullary circuitry is controlled mainly by signals that arise from
he peripheral cardiovascular receptors, especially baroreceptors
nd chemoreceptors, descending signals from different encephalic
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dontologia de Araraquara, UNESP, Rua Humaitá, 1680, Araraquara, 14801 903, SP,
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areas, particularly from forebrain areas, might also inﬂuence the
activity of medullary circuitry and the discharge of the autonomic
projections to the cardiovascular system, allowing more complex
cardiovascular adjustments [28].
Among the forebrain areas involved in the control of the cardio-
vascular function and ﬂuid/electrolyte balance, several studies have
shown the importance of the tissue surrounding the anteroven-
tral third ventricle (AV3V region) [7,10,11,28,32]. The AV3V region
includes the organ vasculosum of lamina terminalis, an area lack-
ing blood–brain barrier and rich in angiotensin II (ANG II) receptors,
the ventral part of the median preoptic nucleus and the periven-
tricular preoptic area. Electrolytic lesions of the AV3V region impair
the development of some models of experimental hypertension
and abolish the pressor responses to intracerebroventricular (i.c.v.)
administration of ANG II or the cholinergic agonist carbachol
[10,11,14,15,32,33]. Moreover, lesions of the AV3V region reduce
vasopressin secretion and increase baroreﬂex sensitivity to ANG II
without changing the baroreﬂex responses to intravenous phenyle-
phrine and sodium nitroprusside [7,10,11,28,32,39].
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The RVLM, located ventrally to the NA, is a main central site that
ctivates sympathetic pre-ganglionic neurons in the spinal cord
3,13,16,17,22,23,35,38]. The activity of the RVLM is inﬂuenced by
nhibitory signals from baroreceptors and excitatory signals from
hemoreceptors and from forebrain areas like the paraventricular
ucleus of the hypothalamus [1,21,24,34]. The amino acid GLU, ANG
I and acetylcholine are important excitatory neurotransmitters in
he RVLM [3,5,8,18,26,31,38].
A previous study showed that the pressor responses produced
y GLU injected into the RVLM in unanesthetized rats are reduced
y acute or chronic lesions of the AV3V region, suggesting a
acilitatory role of the AV3V region for the activation of pressor
echanisms by glutamatergic activation in the RVLM [42]. Simi-
ar to the injection of GLU, injections of ANG II or carbachol into
he RVLM also increase sympathetic activity and MAP  [5,30,40,44].
herefore, in the present study, we investigated the effects of the
V3V lesions in the pressor responses produced by the injection of
NG II or carbachol into the RVLM in unanesthetized rats.
. Materials and methods
.1. Animals
Male Holtzman rats (280–320 g) were used. The animals were
oused individually in stainless steel cages in a room with con-
rolled temperature (23 ± 2 ◦C) and humidity (55 ± 10%). Lights
ere on from 7:00 am to 7:00 pm.  Guabi rat chow and tap water
ere available ad libitum. The Ethical Committee for Animal Care
nd Use from Dentistry School of Araraquara approved the experi-
ental protocols.
.2. Electrolytic AV3V lesion
Rats were anesthetized with ketamine (80 mg/kg of body
eight) plus xylazine (7 mg/kg of body weight) and placed in
 two-arm stereotaxic frame (model 900, David Kopf Instru-
ents). A tungsten wire electrode (0.4 mm in diameter) bared
t the tip (0.5 mm)  was  inserted into the brain using the coor-
inates: 0.0 mm from bregma, in the midline and 7.0 mm below
ura mater. Electrolytic lesions were performed using a cath-
de current (2 mA  for 10 s). Sham lesioned rats had the electrode
laced along the same coordinates, except that no current was
assed.
.3. Implant of cannulas in the RVLM
Immediately after AV3V lesions, a stainless steel cannula
10 × 0.6 mm o.d.) was implanted into the RVLM using the coor-
inates 3.7 mm caudal to lambda, 1.9 mm lateral to midline and
.0 mm below dura mater. The cannula was ﬁxed to the cranium
sing dental acrylic resin and jeweler screws.
At the end of the surgery, the rats received an intramuscular
enicillin injection (30,000 IU) and a subcutaneous injection of the
nalgesic ketoprofen 1%. The rats were maintained individually in
ages with free access to water, food pellets and 10% sucrose to
revent the dehydration due the acute adipsia caused by the AV3V
esion.
.4. Arterial pressure and heart rate recordings
Mean arterial pressure (MAP) and heart rate (HR) were recorded
n unanesthetized rats. On the day before the recording, rats were
nesthetized with ip ketamine + xylazine and a polyethylene tub-
ng was inserted into the abdominal aorta through the femoral
rtery for MAP  and HR recordings. The catheter was  tunneled sub-
utaneously and exposed on the back of the rat to allow access inLetters 556 (2013) 32– 36 33
unrestrained, freely moving rats. For the recordings, the arterial
catheter was  connected to a pressure transducer coupled to a pre-
ampliﬁer connected to a Powerlab data acquisition system (16SP,
ADInstruments).
2.5. Injection into the RVLM
Injections into the RVLM were performed using 5-l  Hamilton
syringes connected by polyethylene tubing to the injector needle
(1.5 mm longer than the guide cannula). The injection volume was
100 nl.
2.6. Histology
At the end of the experiments, 2% Evans blue solution (100 nl)
was injected into the RVLM. The animals were deeply anesthetized
with sodium thiopental (70 mg/kg, ip). Saline followed by 10%
buffered formalin was  perfused through the heart. The brains were
frozen, cut coronally (50 m sections), stained with Giemsa stain
and analyzed by light microscopy to conﬁrm the injections into the
RVLM and the site of AV3V lesion.
2.7. Statistical analysis
The results are reported as means ± standard error of means
(SEM). Two  way repeated measure ANOVA and Newman Keuls tests
were used for comparisons. Differences were considered signiﬁcant
at p < 0.05.
2.8. Experimental protocols
One day after the implant of the catheters, the arterial catheter
was connected to the pressure transducer. About 20 min after
starting the recording, saline was  injected into the RVLM. Twenty
minutes later, ANG II (200 ng/100 nl) was  injected into the RVLM
and MAP  and HR were recorded during 30 min. Six hour later, the
same procedure was  repeated and carbachol (1 nmol/100 nl) was
injected into the RVLM instead of ANG II.
Baseline MAP  and HR and the maximum change (peak change)
of MAP  and HR produced by the injections were analyzed. Baseline
MAP  and HR represents the average of the last 5 min  before injec-
tion into the RVLM. The maximum changes were calculated from a
steady state just before the injection.
3. Results
3.1. Histological analysis
Injections into the RVLM were ventral to the NA (approximately
200–400 m caudal to the facial nucleus). The AV3V lesions were
located between the anterior commissure and the ﬂoor of the third
ventricle with bilateral periventricular damage from the lamina
terminal is to the preoptic area and anterior hypothalamus, never
extending caudally to the arcuate nucleus or laterally to the medial
hypothalamus (Fig. 1). A total of 70 rats were used (38 submitted
to AV3V lesions and 32 with sham lesions, all of them with RVLM
cannula).
3.2. Cardiovascular responses to ANG II or carbachol injected into
the RVLM in AV3V lesioned rat
Baseline MAP  was not modiﬁed by the acute or chronic AV3V
lesion. Injections of ANG II or carbachol into the RVLM induced pres-
sor responses in acute or chronic sham lesioned rats (Figs. 2 and 3).
Acute or chronic AV3V lesions reduced the pressor responses to
ANG II injected into the RVLM, without changing carbachol-induced
34 A.A. Vieira et al. / Neuroscience Letters 556 (2013) 32– 36
F
(
n
p
a
a
p
Fig. 3. Representative recordings showing the typical changes in pulsatile arterial
F
i
cig. 1. Photomicrographs of brain slices from one representative rat showing
arrows) the typical site of (A) AV3V lesion and (B) injections into the RVLM;
a  = nucleus ambiguus; ac = anterior commissure.ressor responses (Figs. 2 and 3). ANOVA showed signiﬁcant inter-
ction between acute groups and drugs [F(2,22) = 6.31; p < 0.05]
nd signiﬁcant difference between chronic groups [F(1,13) = 5.14;
 < 0.05]. Incomplete AV3V lesions did not affect the pressor
ig. 2. Maximum changes in MAP  and HR in (A) acute and (B) chronic sham or AV3V les
njected  into the RVLM. The results are represented by means ± standard error of means (
alculated from baseline immediately before injections.pressure (PAP), mean arterial pressure (MAP) and heart rate (HR) in response to (A)
ANG II (200 ng/100 nl) and (B) carbachol (1 nmol/100 nl) injected into the RVLM in
sham and AV3V lesioned rats (1 and 15 days).
response to ANG II injected into the RVLM and injections of ANG II or
carbachol outside the RVLM did not signiﬁcantly change MAP  or HR.
Acute AV3V lesions increased the baseline HR, whereas chronic
AV3V lesions did not affect baseline HR. Injections of ANG II or
ioned rats treated with saline, ANG II (200 ng/100 nl) or carbachol (1 nmol/100 nl)
SEM). The number of rats is indicated in parenthesis above each bar. Changes were
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arbachol into the RVLM produced no signiﬁcant change in HR in
cute or chronic sham- or AV3V-lesioned rats (Figs. 2 and 3).
. Discussion
Previous results showed that acute or chronic lesions of the
V3V region attenuated the pressor response produced by the
njection of GLU into the RVLM [42]. The present results show that
cute or chronic AV3V lesions also affect the pressor response to
NG II injected into the RVLM in unanesthetized rats. Therefore the
resent and the previous results suggest that facilitatory mecha-
isms from the AV3V region are important for the pressor response
o glutamatergic or angiotensinergic activation of the RVLM. More-
ver, they suggest that the AV3V mechanisms are important for the
ressor responses produced by the action of speciﬁc neurotrans-
itters in the RVLM.
Central angiotensinergic and cholinergic mechanisms
ave important roles in the cardiovascular regulation
8,9,19,31,33,43,44]. Acetylcholine and ANG II receptors are
resent in the RVLM [2,4,27,29] and the activation of these recep-
ors increases sympathetic activity and MAP  [6,20,25,29,34,36].
lthough similar pressor mechanisms seem to be activated by
ngiotensinergic or cholinergic stimulation in the RVLM, AV3V
esions reduced the pressor response to ANG II without changing
he response to carbachol injected into the RVLM. These results are
imilar to those of a previous study showing that acute or chronic
V3V lesions block the pressor response to GLU [41], but not to
ubstance P, injected into the NTS. Therefore, there are speciﬁc
indbrain pressor mechanisms that depend on facilitatory signals
rom the AV3V region to be completely activated. Importantly,
he AV3V lesions impair the development of many forms of
xperimental hypertension in rats and, therefore, the reduced
ction of angiotensinergic and glutamatergic pressor mechanisms
n the RVLM might play a role in the anti-hypertensive effect of the
V3V lesion [10,11]. Interestingly, injection of the AT1 receptor
ntagonists losartan or ZD 7155 into the RVLM reduced the pressor
esponse to GLU injected into the same area, which suggests an
nteraction between angiotensinergic and glutamatergic pressor
echanisms in the RVLM [44]. This interaction might explain
hy AV3V lesions affect the pressor response to GLU and ANG II
njected into the RVLM.
Increases in HR and slight or no increase in MAP have been
eported in the ﬁrst days after AV3V lesions [32]. Additionally,
revious studies have shown that the cardiovascular responses pro-
uced by chemoreﬂex or baroreﬂex activation are not modiﬁed by
cute or chronic AV3V lesions [41,42]. Therefore, the effects pro-
uced by AV3V lesion on the pressor responses to ANG II into the
VLM are not due to any change on baseline MAP  or any impair-
ent of baro or chemoreﬂex responses. Although the AV3V lesions
roduce transitory adipsia (in the ﬁrst 5–7 days) and chronic hyper-
atremia [10,11], these changes in ﬂuid electrolyte balance are
robably not the cause of the reduction in the pressor responses
o ANG II. Acute and chronic AV3V lesions reduced the pressor
esponse to injections of ANG II into the RVLM, whereas adipsia was
resent only acutely and hypernatremia is suggested to increase the
ressor response to the activation of the RVLM, instead of reducing
t [12]. In addition, the AV3V lesions impaired the pressor response
o ANG II, but not to carbachol, into the RVLM which suggests that
here are speciﬁc pressor mechanisms in the RVLM modiﬁed by the
V3V lesions.
In spite of the importance of the medullary circuitry that
ncludes the RVLM for the cardiovascular control, the AV3V region
as been shown to play important role in the control of pres-
or responses that depend on sympathetic activation [10,11,41].
esions of the AV3V region reduce arterial pressure in different
odels of experimental hypertension, the pressor responses toLetters 556 (2013) 32– 36 35
i.c.v. injections of ANG II or the cholinergic agonist carbachol, or
to injections of GLU into the RVLM or the NTS, which suggests that
important pressor mechanisms activated in these conditions are
under the control of the AV3V region [10,11,14,15,32,33,39,41].
Neurons from the RVLM directly activate pre-motor sympathetic
ﬁbers in the intermediolateral column in the spinal cord (IML)
[13,17,24] and, therefore, the activation of the RVLM neurons
with ANG II is expected to directly activate sympathetic mecha-
nisms that produce pressor responses. However, the present results
suggest that the AV3V lesions reduce the sympathetic activation
produced by ANG II injected into the RVLM. The mechanisms
involved in these effects of the AV3V lesions are not clear. One
possibility is the reduction of the excitability of the RVLM neurons
that are activated by ANG II, which results in reduced sympathetic
activation. The reduction in the neuronal excitability of the RVLM
neurons might be caused by the reduction of facilitatory signals or
the increase of inhibitory signals to the RVLM. The RVLM receives
inhibitory and excitatory inﬂuences from different hindbrain and
forebrain areas [1,16,17,24]. As suggested by a previous study [42],
the AV3V lesions may  produce an imbalance in those inﬂuences,
by either reducing facilitatory or increasing inhibitory signals, or
both, to the RVLM, thus reducing the excitability of RVLM neurons
involved in sympathetic activation produced by glutamatergic or
angiotensinergic mechanisms. The neuronal activity of the RVLM
is facilitated by central angiotensinergic mechanisms [17] and the
AV3V lesions reduce the release of excitatory signals from the
forebrain angiotensinergic mechanisms to increase sympathetic
activity [10,11,28], which may  reduce the excitability of the RVLM
neurons. Although the decrease in the RVLM excitability is a possi-
ble mechanism, AV3V lesions might also reduce pressor responses
by directly changing the excitability of sympathetic neurons in the
IML.
In conclusion, the present study demonstrated that the integrity
of the AV3V region is necessary for the full expression of the pressor
response induced by angiotensin II injected into the RVLM. This
suggests that the AV3V region modulates the excitability of the
RVLM neurons involved with the pressor response produced by the
activation of angiotensinergic mechanisms in this area.
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